[1]
I. F. MacKay, J. M. Garrah, B. M. Tabah, L. Freeman, M. M. Maher, and C. L. Macdonald, “ADVERSE DRUG REACTIONS ASSOCIATED WITH THE USE OF RIBAVIRIN IN THE TREATMENT OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS)”, J Popl Ther Clin Pharmacol, vol. 12, no. 1, Dec. 2018, Accessed: Nov. 19, 2024. [Online]. Available: https://mail.jptcp.com/index.php/jptcp/article/view/79